Cargando…
The Prevalence of Multiple Sclerosis in 3 US Communities
INTRODUCTION: We estimated the prevalence of multiple sclerosis (MS) in 3 large geographic areas in the southern, middle, and northern United States. METHODS: The primary data source was medical records from office visits to private neurologists' practices or to neurology departments in tertiar...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811507/ https://www.ncbi.nlm.nih.gov/pubmed/20040227 |
_version_ | 1782176777348579328 |
---|---|
author | Williamson, Dhelia M. Noonan, Curtis W. Henry, Judy P. Wagner, Laurie Indian, Robert Lynch, Sharon G. Neuberger, John S. Schiffer, Randolph Trottier, Janine Marrie, Ruth Ann |
author_facet | Williamson, Dhelia M. Noonan, Curtis W. Henry, Judy P. Wagner, Laurie Indian, Robert Lynch, Sharon G. Neuberger, John S. Schiffer, Randolph Trottier, Janine Marrie, Ruth Ann |
author_sort | Williamson, Dhelia M. |
collection | PubMed |
description | INTRODUCTION: We estimated the prevalence of multiple sclerosis (MS) in 3 large geographic areas in the southern, middle, and northern United States. METHODS: The primary data source was medical records from office visits to private neurologists' practices or to neurology departments in tertiary care facilities during a 3-year period. Additional data sources included patient advocacy groups, nursing homes, and general practitioners. RESULTS: Three-year US age-adjusted prevalence estimates for the study areas varied substantially. The prevalence was lowest (47.2 per 100,000 population) in the Texas study area (33°30′ north latitude), intermediate (86.3 per 100,000 population) in the Missouri study area (39°07′ north latitude), and highest (109.5 per 100,000 population) in the Ohio study area (41°24′ north latitude). The geographic differences remained strong after age-adjustment to the world standard population. The inverse association between UV light exposure and MS prevalence estimates was consistent with this observed latitude gradient. In all 3 areas, MS prevalence was highest among women, people aged 40 to 59 years, and non-Hispanics. CONCLUSION: These results provide necessary prevalence estimates for community cluster investigations and establish baseline estimates for future studies to evaluate temporal trends in disease prevalence. |
format | Text |
id | pubmed-2811507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-28115072010-02-03 The Prevalence of Multiple Sclerosis in 3 US Communities Williamson, Dhelia M. Noonan, Curtis W. Henry, Judy P. Wagner, Laurie Indian, Robert Lynch, Sharon G. Neuberger, John S. Schiffer, Randolph Trottier, Janine Marrie, Ruth Ann Prev Chronic Dis Original Research INTRODUCTION: We estimated the prevalence of multiple sclerosis (MS) in 3 large geographic areas in the southern, middle, and northern United States. METHODS: The primary data source was medical records from office visits to private neurologists' practices or to neurology departments in tertiary care facilities during a 3-year period. Additional data sources included patient advocacy groups, nursing homes, and general practitioners. RESULTS: Three-year US age-adjusted prevalence estimates for the study areas varied substantially. The prevalence was lowest (47.2 per 100,000 population) in the Texas study area (33°30′ north latitude), intermediate (86.3 per 100,000 population) in the Missouri study area (39°07′ north latitude), and highest (109.5 per 100,000 population) in the Ohio study area (41°24′ north latitude). The geographic differences remained strong after age-adjustment to the world standard population. The inverse association between UV light exposure and MS prevalence estimates was consistent with this observed latitude gradient. In all 3 areas, MS prevalence was highest among women, people aged 40 to 59 years, and non-Hispanics. CONCLUSION: These results provide necessary prevalence estimates for community cluster investigations and establish baseline estimates for future studies to evaluate temporal trends in disease prevalence. Centers for Disease Control and Prevention 2009-12-15 /pmc/articles/PMC2811507/ /pubmed/20040227 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Original Research Williamson, Dhelia M. Noonan, Curtis W. Henry, Judy P. Wagner, Laurie Indian, Robert Lynch, Sharon G. Neuberger, John S. Schiffer, Randolph Trottier, Janine Marrie, Ruth Ann The Prevalence of Multiple Sclerosis in 3 US Communities |
title | The Prevalence of Multiple Sclerosis in 3 US Communities |
title_full | The Prevalence of Multiple Sclerosis in 3 US Communities |
title_fullStr | The Prevalence of Multiple Sclerosis in 3 US Communities |
title_full_unstemmed | The Prevalence of Multiple Sclerosis in 3 US Communities |
title_short | The Prevalence of Multiple Sclerosis in 3 US Communities |
title_sort | prevalence of multiple sclerosis in 3 us communities |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811507/ https://www.ncbi.nlm.nih.gov/pubmed/20040227 |
work_keys_str_mv | AT williamsondheliam theprevalenceofmultiplesclerosisin3uscommunities AT noonancurtisw theprevalenceofmultiplesclerosisin3uscommunities AT henryjudyp theprevalenceofmultiplesclerosisin3uscommunities AT wagnerlaurie theprevalenceofmultiplesclerosisin3uscommunities AT indianrobert theprevalenceofmultiplesclerosisin3uscommunities AT lynchsharong theprevalenceofmultiplesclerosisin3uscommunities AT neubergerjohns theprevalenceofmultiplesclerosisin3uscommunities AT schifferrandolph theprevalenceofmultiplesclerosisin3uscommunities AT trottierjanine theprevalenceofmultiplesclerosisin3uscommunities AT marrieruthann theprevalenceofmultiplesclerosisin3uscommunities AT williamsondheliam prevalenceofmultiplesclerosisin3uscommunities AT noonancurtisw prevalenceofmultiplesclerosisin3uscommunities AT henryjudyp prevalenceofmultiplesclerosisin3uscommunities AT wagnerlaurie prevalenceofmultiplesclerosisin3uscommunities AT indianrobert prevalenceofmultiplesclerosisin3uscommunities AT lynchsharong prevalenceofmultiplesclerosisin3uscommunities AT neubergerjohns prevalenceofmultiplesclerosisin3uscommunities AT schifferrandolph prevalenceofmultiplesclerosisin3uscommunities AT trottierjanine prevalenceofmultiplesclerosisin3uscommunities AT marrieruthann prevalenceofmultiplesclerosisin3uscommunities |